Man buys rights to AIDS drug, raises price from $13.50 to $750 a pill

When former hedge fund manager Martin Shkreli took over the rights to Daraprim as founder of Turing Pharmaceuticals, he conveniently raised the price ‘overnight’ to the all American tune of an 'almost 5,500 percent increase’ in price. Daraprim is used to treat toxoplasmosis, a parasitic infection that’s capable of causing life-threatening complications in infants and for 'people with compromised immune systems,’ such as those with AIDS and even 'certain’ cancer patients. Shortly after the price hike spawned a lot of stories, Shkreli took to television in an attempt to clarify the necessity of the 5,500 percent increase and voice his support of a profit-driven healthcare market.

This isn’t the greedy drug company trying to gouge patients, it is us trying to stay in business.

Martin Shkreli.

Health Martin Shkreli